Search Results - "Lysen, Anna"

Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infection by Lysén, Anna, Gudjonsson, Arnar, Tesfaye, Demo Yemane, Bobic, Sonja, Bern, Malin, Bogen, Bjarne, Fossum, Even

“…Targeting antigens to dendritic cells represent a promising method for enhancing immune responses against specific antigens. However, many studies have focused…”
Get full text

Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site by Lysén, Anna, Braathen, Ranveig, Gudjonsson, Arnar, Tesfaye, Demo Yemane, Bogen, Bjarne, Fossum, Even

“…Fusing antigens to chemokines to target antigen presenting cells (APC) is a promising method for enhancing immunogenicity of DNA vaccines. However, it is…”
Get full text

Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection by Tesfaye, Demo Yemane, Bobic, Sonja, Lysén, Anna, Huszthy, Peter Csaba, Gudjonsson, Arnar, Braathen, Ranveig, Bogen, Bjarne, Fossum, Even

“…Targeting antigen to conventional dendritic cells (cDCs) can improve antigen-specific immune responses and additionally be used to influence the polarization…”
Get full text

Targeting Influenza Virus Hemagglutinin to Xcr1 + Dendritic Cells in the Absence of Receptor-Mediated Endocytosis Enhances Protective Antibody Responses by Gudjonsson, Arnar, Lysén, Anna, Balan, Sreekumar, Sundvold-Gjerstad, Vibeke, Arnold-Schrauf, Catharina, Richter, Lisa, Bækkevold, Espen S, Dalod, Marc, Bogen, Bjarne, Fossum, Even

“…Targeting Ags to conventional dendritic cells can enhance Ag-specific immune responses. Although most studies have focused on the induction of T cell…”
Get full text

Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation by Nørgaard, Jakob Nordberg, Abildgaard, Niels, Lysén, Anna, Tsykunova, Galina, Vangsted, Annette Juul, João, Cristina, Remen, Nora, Nielsen, Lene Kongsgaard, Osnes, Liv, Stokke, Caroline, Connelly, James P., Revheim, Mona-Elisabeth R., Schjesvold, Fredrik

“…18 F-Fluorodeoxyglucose positron emission tomography/computed tomography (PET) positivity after first-line treatment with autologous stem cell transplantation…”
Get full text

PB2118: TG01‐STUDY: A PHASE 1/2 STUDY WITH TG01 IMMUNOTHERAPY VACCINATION IN PATIENTS WITH CONFIRMED NRAS/KRAS MUTATION ON CODON 12/13 AND MULTIPLE MYELOMA OR HIGH‐RISK SMOLDERING MYELOMA by Monsen, Hedda, Norseth, Hanne Marie, Remen, Nora, Abrahamsen, Ingerid, Lysén, Anna, Schjesvold, Fredik

Get full text

P875: REPLACING STEROIDS IN TRANSPLANT‐INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB‐BORTEZOMIB‐LENALIDOMIDE‐DEXAMETHASONE REST STUDY by Bugge Askeland, Frida, Haukås, Einar, Slørdahl, Tobias S., Klostergaard, Anja, Alexandersen, Tatjana, Schjøll, Diana, Lysén, Anna, Hermansen, Emil, Schjesvold, Fredrik

Get full text

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study by Askeland, Frida Bugge, Haukås, Einar, Slørdahl, Tobias S., Klostergaard, Anja, Alexandersen, Tatjana, Schjøll, Diana, Lysen, Anna, Hermansen, Emil, Schjesvold, Fredrik

“…Background: Standard therapies for patients with newly diagnosed multiple myeloma (NDMM) who are ineligible for autologous stem cell transplantation (ASCT)…”
Get full text

P832: PROSPECTIVE REAL‐WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY by Gavriatopoulou, Maria, Spencer, Andrew, Coriu, Daniel, Escalante Barrigón, Fernando, Hájek, Roman, Seguro, Fernanda, Gutiérrez, Norma C., Basic Kinda, Sandra, Offidani, Massimo, Fantl, Dorotea Beatriz Eugenia, Bittencourt, Rosane, Lysén, Anna, Maisnar, Vladimir, Askari, Elham, Martinez‐Lopez, Joaquín, Hughes, Olivia, Taylor, Rebekah, Lehn, Kristin, Joehanes, Roby, Ross, Jeremy, Hader, Carlos

Get full text

Differences in Fcgamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali by Israelsson, Elisabeth, Vafa, Manijeh, Maiga, Bakary, Lysén, Anna, Iriemenam, Nnaemeka C, Dolo, Amagana, Doumbo, Ogobara K, Troye-Blomberg, Marita, Berzins, Klavs

“…The Ig Fc receptor family is an important link between the humoral and cellular immune systems. The association of a dimorphism in amino acid 131 (R/H) of the…”
Get full text

Will Survival Improve By Treating Multiple Myeloma Patients at MRD Relapse? the Remnant Study by Askeland, Frida Bugge, Rasmussen, Anne-Marie, Lysen, Anna, Haukås, Einar, Eilertsen, Anette Løken, Moksnes, Magnus, Tsykunova, Galina, Vik, Anders, Eiken, Birgitte Dahl, Stavseth, Vidar, Rolke, Jürgen, Samstad, Eivind Ottersen, Peceliunas, Valdas, Hallstensen, Randi Fykse, Hansen, Ariane Aasbø, Nilsen, Anita Smith, Slørdahl, Tobias S., Schjesvold, Fredrik

“…Background: Although many new treatment options have become available, multiple myeloma (MM) is still considered an incurable disease. The importance of…”
Get full text

Upfront Autologous Stem Cell Transplantation in Myeloma Patients >65 Years: A Population-Based Study from the Nordic Myeloma Study Group by Moore, Kari Lenita Falck, Genell, Anna, Kaare, Ain, Knut-Bojanowska, Dorota, Loigom, Diana, Lysen, Anna, Nordberg Nørgaard, Jakob, Palk, Katrin, Pärnat, Maris, Peceliunas, Valdas, Rögnvaldsson, Sæmundur, Schjesvold, Fredrik, Sigurdsson, Alexander, Szabo, Agoston Gyula, Thorsen, Jonathan, Thorsteinsdottir, Sigrun, Vaitekėnaitė, Vilmantė, Vangsted, Annette J., Blimark, Cecilie Hveding

“…Background Current guidelines recommend upfront autologous stem cell transplantation (ASCT) as part of first line treatment of newly diagnosed multiple myeloma…”
Get full text

P-082 Will survival improve by treating multiple myeloma patients at MRD relapse? The REMNANT study by Rasmussen, Anne-Marie, Askeland, Frida, Lysen, Anna, Haukås, Einar, Eilertsen, Anette, Tsykunova, Galina, Vik, Anders, Eiken, Birgitte, Stavseth, Vidar, Rolke, Jürgen, Samstad, Eivind, Peceliunas, Valdas, Hallstensen, Randi Fykse, Hansen, Ariane Aasbø, Nilsen, Anita Smith, Slørdahl, Tobias, Schjesvold, Fredrik

Get full text

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study by Askeland, Frida Bugge Bugge, Haukås, Einar, Slørdahl, Tobias S., Schjøll, Diana, Lysén, Anna, Hermansen, Emil, Schjesvold, Fredrik

Get full text

Carfilzomib-Lenalidomide-Dexamethasone Consolidation in Myeloma Patients with a Positive FDG PET/CT after Upfront Autologous Stem Cell Transplantation: A Phase II Study (CONPET) by Nørgaard, Jakob Nordberg, Abildgaard, Niels, Lysén, Anna, Tsykunova, Galina, Vangsted, Annette Juul, João, Cristina, Remen, Nora, Connelly, James P, Revheim, Mona-Elisabeth R., Schjesvold, Fredrik H.

“…Background: [18F]-Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) positivity after first line treatment with autologous stem…”
Get full text

Carfilzomib-Based Regimens Are Efficacious and Well Tolerated in Heavily Pre-Treated Multiple Myeloma Patients: Real World Data from a Norwegian Cohort by Lysén, Anna, Haarstad, Ina, Schjesvold, Fredrik H.

“…Introduction Multiple myeloma (MM) is considered an incurable disease. However, during the last years the survival has improved, partly due to the development…”
Get full text

P-276 Vaccinating Against Mutated RAS in Multiple Myeloma: The Phase I/II TG01 Study by Norseth, Hanne, Monsen, Hedda, Remen, Nora, Inderberg, Else Marit, Vålerhaugen, Helen, Bergly, Laila Helene, Lysén, Anna, Abrahamsen, Ingerid Weum, Schjesvold, Fredrik

Get full text

Krd Consolidation in Myeloma Patients with a Positive PET-CT after Standard First Line Treatment: A Phase II Study (CONPET) by Nørgaard, Jakob Nordberg, Abildgaard, Niels, Lysén, Anna, Revheim, Mona-Elisabeth R, Connelly, James P, Schjesvold, Fredrik H.

“…Background: [18F]-Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) positivity after first line treatment with autologous stem…”
Get full text

Predictors of Overall Survival for Multiple Myeloma Patients Depending on Transplant Status According to a Retrospective, Non-Interventional Study in Norway by Schjesvold, Fredrik H., Jenna, Anderson, Sõnajalg, Jaak, Leval, Amy, Lysén, Anna, Rana, Saeeda, Castren-Kortekangas, Päivi, Borgsten, Fredrik

“…Introduction Multiple myeloma (MM) is the second most common hematological malignancy in Europe and the US. The median survival after diagnosis is…”
Get full text

Author Correction: Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site by Lysén, Anna, Braathen, Ranveig, Gudjonsson, Arnar, Tesfaye, Demo Yemane, Bogen, Bjarne, Fossum, Even

“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text